Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vijaya Diagnostic CentreBOM:543350 +0.10%83 Return-on-Tangible-Equity is 23.47% as of Mar. 2026, which is 2% below its 10-year median of 24.03. GuruFocus rates BOM:543350 with a GF Score™ of 83/100 and a GF Value™ of ₹1,201.08 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 191 Medical Diagnostics & Research companies, Vijaya Diagnostic Centre ranks better than 76.44% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Vijaya Diagnostic Centre's annualized net income for the quarter that ended in Mar. 2026 was ₹1,917 Mil. Vijaya Diagnostic Centre's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹8,167 Mil. Therefore, Vijaya Diagnostic Centre's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 23.47%.
The historical rank and industry rank for Vijaya Diagnostic Centre's Return-on-Tangible-Equity or its related term are showing as below:
BOM:543350'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 16.96 Med: 24.03 Max: 27.27
Current: 23.6
During the past 8 years, Vijaya Diagnostic Centre's highest Return-on-Tangible-Equity was 27.27%. The lowest was 16.96%. And the median was 24.03%.
BOM:543350's Return-on-Tangible-Equity is ranked better than 76.44% of 191
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.07
vs BOM:543350: 23.60
Vijaya Diagnostic Centre (BOM:543350) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Vijaya Diagnostic Centre Return-on-Tangible-Equity Related Terms
Vijaya Diagnostic Centre Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Vijaya Diagnostic Centre's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vijaya Diagnostic Centre Return-on-Tangible-Equity Chart
BOM:543350 vs TMO, DHR, IDXX: Return-on-Tangible-Equity Comparison
For the Diagnostics & Research subindustry, Vijaya Diagnostic Centre's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vijaya Diagnostic Centre Return-on-Tangible-Equity vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Vijaya Diagnostic Centre's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Vijaya Diagnostic Centre's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 23.47% mean?
Vijaya Diagnostic Centre (BOM:543350) has a Return-on-Tangible-Equity of 23.47% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Vijaya Diagnostic Centre and its competitors. This is near median its historical median of 24.03. Over the past decade, Vijaya Diagnostic Centre's Return-on-Tangible-Equity has ranged from 16.96 to 27.27. According to the industry distribution chart, Vijaya Diagnostic Centre ranks #45 out of 191 companies in the Medical Diagnostics & Research industry, placing it in the top 23.6%.
Is Vijaya Diagnostic Centre's Return-on-Tangible-Equity too high?
Vijaya Diagnostic Centre's current Return-on-Tangible-Equity of 23.47% is near median its 10-year median of 24.03. Over the past 10 years, this metric has ranged from a low of 16.96 to a high of 27.27. The Medical Diagnostics & Research industry median Return-on-Tangible-Equity is 0.07. Vijaya Diagnostic Centre's value of 23.47% is 33428.6% above this industry median. Based on the distribution chart, Vijaya Diagnostic Centre ranks #45 out of 191 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Vijaya Diagnostic Centre has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vijaya Diagnostic Centre's Return-on-Tangible-Equity compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vijaya Diagnostic Centre ranks #45 out of 191 companies for Return-on-Tangible-Equity. This places Vijaya Diagnostic Centre in the top 24% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 0.07. Vijaya Diagnostic Centre's value of 23.47% is 33428.6% above this benchmark. Historically, Vijaya Diagnostic Centre's own Return-on-Tangible-Equity has ranged from 16.96 to 27.27 over the past decade. While the company's 10-year median is 24.03 vs. the industry median of 0.07, Vijaya Diagnostic Centre has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Diagnostics & Research company?
The median Return-on-Tangible-Equity among Medical Diagnostics & Research companies is 0.07, based on 191 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vijaya Diagnostic Centre's current Return-on-Tangible-Equity of 23.47% is 33428.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Vijaya Diagnostic Centre and its competitors. For the Medical Diagnostics & Research industry, the median Return-on-Tangible-Equity is 0.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vijaya Diagnostic Centre's current Return-on-Tangible-Equity is 23.47%, which is near median its own 10-year median of 24.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaya Diagnostic Centre stock overvalued right now?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre (BOM:543350) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,201.08, compared to a current price of ₹1,349.45 — trading 12.4% above its estimated fair value. The current Return-on-Tangible-Equity is 23.47%, which is near median its 10-year median of 24.03 and 33428.6% above the Medical Diagnostics & Research industry median of 0.07. Vijaya Diagnostic Centre's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Vijaya Diagnostic Centre (BOM:543350), the current Return-on-Tangible-Equity is 23.47% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vijaya Diagnostic Centre (BOM:543350) Overvalued in 2026?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre stock appears to be overvalued.
The current stock price of ₹1,349.45 is trading 12.4% above its estimated GF Value™ of ₹1,201.08.
GuruFocus considers Vijaya Diagnostic Centre to be Modestly Overvalued.
Key valuation signals for BOM:543350:
Return-on-Tangible-Equity: 23.47% (near median its 10-year median of 24.03)
GF Value™: ₹1,201.08 vs. price of ₹1,349.45 (12.4% above fair value)
Industry Position: 33428.6% above the Medical Diagnostics & Research median (#45 of 191)
No single metric tells the full story. See the BOM:543350 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vijaya Diagnostic Centre Ltd operates a diagnostic chain in Southern India. The company offers a one-stop solution for pathology and radiology testing services. It provides routine tests, specialized pathology tests, basic tests, and radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers. The company's revenue comes from many diagnostic centers, where high-volume sales drive its earnings. The Company operates within India. The company's operations fall within a single business segment, which is Diagnostic Services.
83GF Score
Get the complete analysis for BOM:543350
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543350 has been successfully added to your 
